-
Amaryl
- -Generic: glimepiride
- -Class: Sulfonylurea
- -Indication: Oral Type 2 Diabetes
- -MOA: increase endogenous insulin secretion; reduces rate of hepatic glucose production
- -Adverse Effects: hypoglycemia, weight gain
- -Patient Education:
- -Other:
-
Micronase, Glynase, DiaBeta
- -Generic: glyburide
- -Class: Sulfonylureas
- -Indication: Oral Type 2 Diabetes
- -MOA: increase endogenous insulin secretion; reduce rate of hepatic glucose production
- -Adverse Effects: hypoglycemia, weight gain
- -Patient Education:
- -Other:
-
Glucotrol (XL)
- -Generic: glipizide
- -Class: Sulfonylureas
- -Indication: Oral Type 2 Diabetes
- -MOA: increase endogenous insulin secretion; reduce rate of hepatic glucose production
- -Adverse Effects: hypoglycemia, weight gain
- -Patient Education:
- -Other:
-
Actos
- -Generic: pioglitazone
- -Class: Thiazolidinediones
- -Indication: Oral Type 2 Diabetes
- -MOA: decrease insulin resistance by making muscle and adipose cells more sensitive to insulin; suppress hepatic glucose production
- -Adverse Effects: weight gain, edema, hypoglycemia
- -Patient Education: takes 6 weeks for max effect
- -Other: improves HDL and plasma triglycerides; usually LDL neutral; contraindicated in pts. with abnormal liver function
-
Avandia
- -Generic: rosiglitazone
- -Class: Thiazolidinediones
- -Indication: Oral Type 2 Diabetes
- -MOA: decrease insulin resistance by making muscle and adipose cells more sensitive to insulin; suppress hepatic glucose production
- -Adverse Effects: weight gain, edema, hypoglycemia
- -Patient Education: takes 6 weeks for max effect
- -Other: improves HDL and plasma triglycerides; usually LDL neutral; contraindicated in pts. with abnormal liver function***Withdrawn from market bc of cardiovascular risks***
-
Glucophage (XR)
- -Generic: metformin
- -Class: Biguanides
- -Indication: Oral Type 2 Diabetes
- -MOA: decreases hepatic glucose production
- -Adverse Effects:diarrhea, abdominal discomfort, lactic acidosis
- -Patient Education:
- -Other:
-
@Prandin
- -Generic: repaglinide
- -Class: Meglitinides
- -Indication: Oral Type 2 Diabetes
- -MOA: stimulate insulin secretion in presence of glucose
- -Adverse Effects: hypoglycemia (may be <sulfonylureas)
- -Patient Education:
- -Other:
-
@Precose
- @Glyset
- -Generic: acarbose; miglitol
- -Class: Alpha-glucosidase inhibitors
- -Indication: Oral Type 2 Diabetes
- -MOA: blocks enzymes that digests glucose in the small intestine (delays glucose uptake)
- -Adverse Effects: flatulence, abdominal discomfort
- -Patient Education:
- -Other:
-
Januvia
- -Generic: sitagliptin
- -Class: DPP4 Inhibitor
- -Indication: Oral Type 2 Diabetes
- -MOA: stimulates beta cells to release insulin; decreases hepatic glucose production
- -Adverse Effects: GI
- -Patient Education:
- -Other: decreases FBG 10-15 mg/dl; decreases A1C 0.5-0.6%; decrease post-prandial glucose 50mg/dl
-
Byetta
- -Generic: exenatide
- -Class: Incretin mimetic
- -Indication: Oral Type 2 Diabetes
- -MOA: stimulates pancreas to make more insulin; increases beta cell growth/replication
- -Adverse Effects:
- -Patient Education:
- -Other: SQ
-
Glucovance
- -Generic: glyburide with metformin
- -Class: sulfonylurea and biguanide
- -Indication: Oral Type 2 Diabetes
- -MOA:
- -Adverse Effects:
- -Patient Education:
- -Other:
-
NovaLog
- -Generic: insulin aspart
- -Class: Insulins
- -Indication: Diabetes
- -MOA: rapid-acting: works within 10-30 minutes; duration 3-5 hours
- -Adverse Effects:
- -Patient Education:
- -Other:
-
Humulin R, Novolin R
- -Generic: insulin regular
- -Class: Insulins
- -Indication: Diabetes
- -MOA: short-acting: 30-60 minutes to work; duration up to 8 hours
- -Adverse Effects:
- -Patient Education:-Other:
-
Lantus
- -Generic: insulin glargine
- -Class: Insulins
- -Indication: Diabetes
- -MOA: Long-acting: 1-5 hours to start working; duration up to 24 hours
- -Adverse Effects:
- -Patient Education:
- -Other:
-
Humalog
- -Generic: insulin lispro
- -Class: Insulins
- -Indication: Diabetes
- -MOA: rapid-acting: works within 10-30 minutes; duration from 3-5 hours
- -Adverse Effects:
- -Patient Education:
- -Other:
-
Motrin, Advil
- -Generic: ibuprofen
- -Class: NSAID
- -Indication: inflammatory disease, rheumatoid disorders, mild to mod. pain, fever
- -MOA:
- -Adverse Effects: indigestion, abdominal pain, constipation
- -Patient Education: take with food or milk, avoid aspirin
- -Other: Adult Max Dose=3.2g/day; 6 mths of age and older
- Peds Dosing: <102.5=5mg/kg/dose
- >102.5=10mg/kg/dose
- Max Dose= 40 mg/kg/DAY
-
Naprosyn
- -Generic: naproxen
- -Class: NSAID
- -Indication: inflammatory disease, rheumatoid, mild to mod. pain, fever
- -MOA:
- -Adverse Effects: indigestion, abdominal pain, constipation
- -Patient Education:take with food or milk, avoid aspirin
- -Other: Adult max dose= 1200-1650 mg/day
-
Aspirin
- -Class: analgesic, NSAID
- -Indication: mild to mod. pain, inflammation, fever, prevention of MI, inhibit prostaglandin synth
- -MOA:
- -Adverse Effects:bleeding, fatigue, rash, abdominal pain
- -Patient Education: toxic doses=salicyclism (vomiting, vertigo, tinnitus); caution OTC’s
- -Other: contraindicated: hypersensitivities, bleeding disorders (Coumadin) >16 yoa, gout, 3rd trimester, Reye’s syndrome; low v. regular doses (81 or 325 mg)
-
Mobic
- -Generic: meloxicam
- -Class: NSAID
- -Indication: OA, RA, juv. RA
- -MOA:
- -Adverse Effects:edema, HA, dizziness
- -Patient Education: take with food, milk; avoid aspirin
- -Other:
-
Voltaren
- -Generic: diclofenac sodium
- -Class: NSAID
- -Indication: OA, RA
- -MOA:
- -Adverse Effects: nausea, indigestion, constipation
- -Patient Education: take with food or milk, avoid aspirin
- -Other:
-
Cataflam
- -Generic: diclofenac potassium
- -Class: NSAID
- -Indication: OA, RA, pain
- -MOA:
- -Adverse Effects: nausea, indigestion, constipation
- -Patient Education: take with food, milk; avoid aspirin
- -Other:
-
Relafen
- -Generic: nabumetone
- -Class: NSAID
- -Indication: OA, RA
- -MOA:
- -Adverse Effects: abdominal pain, constipation, nausea
- -Patient Education: take with food, milk, avoid aspirin
- -Other:
-
Lodine
- -Generic: etodolac
- -Class: NSAID
- -Indication: OA, RA
- -MOA:
- -Adverse Effects: abdominal pain, constipation, nausea
- -Patient Education: take with food or milk, avoid aspirin
- -Other:
-
Celebrex
- -Generic: celecoxib
- -Class: Selective Cox II NSAID
- -Indication: OA, RA
- -MOA:
- -Adverse Effects: GI irritation, HA may occur
- -Patient Education: similar products taken off the market bc of heart attacks and strokes
- -Other:
-
Tylenol
- -Generic: acetaminophen (APAP)
- -Class: Non-opioid analgesic
- -Indication: mild to mod. pain; fever
- -MOA:
- -Adverse Effects: rash, anemia
- -Patient Education: alcohol use can increase the risk of toxicities
- -Other: very weak inhibitor of COX (no sig. anti-inflammatory effects)
- Max Adult Dose= 4g/day
-
Benadryl
- -Generic: diphenhydramine
- -Class: 1st generation Antihistamine
- -Indication: allergies
- -MOA:
- -Adverse Effects: dizziness, drowsiness, dry mouth
- -Patient Education: enters breast milk, causes drowsiness, fatigue, diarrhea
- -Other: 5 mg/kg/day (divided doses q6-8h)- mod to severe allergic rxn; 1st generation= crosses BBB, short half-life, CNS adverse effects
-
Phenergan
- -Generic: promethazine
- -Class: antiemetic, antihistamine (1st gen), sedative;
- -Indication: allergic rxns, sedation, motion sickness, post-op pain
- -MOA: H1 antagonist, anticholinergic
- -Adverse Effects: drowsiness, dizziness, dry mouth
- -Patient Education: refrigerate suppositories, onset of action: 15-30 minutes, >2 years
- -Other: formulations: tablet, syrup, suppository, injection= PO, IM, PR (IV not recommended extravasation)
-
Tussionex
- -Generic: chlorpheniramine and hydrocodone
- -Class: antitussive
- -Indication: cough relief
- -MOA:
- -Adverse Effects: drowsiness, constipation
- -Patient Education: shake well; avoid alcohol, >6 yoa
- -Other: habit forming
-
Tessalon, Perles
- -Generic: benzonatate
- -Class: antitussive
- -Indication: cough relief
- -MOA:
- -Adverse Effects: life-threatening rxns: tetracaine, procaine; HA, constipation, nausea
- -Patient Education: don’t crush or chew, >10yoa
- -Other:
-
Prilosec
- -Generic: omeprazole
- -Class: PPI
- -Indication: mod. to severe GERD
- -MOA: blocks the secretion of acid into the stomach by the parietal cells
- -Adverse Effects:
- -Patient Education: OTC; can sprinkle on applesauce; take 1 hour before meals; avoid alcohol
- -Other: protects esophagus so it can heal; may also strengthen LES
-
Nexium
- -Generic: esomeprazole
- -Class: PPI
- -Indication: mod. to severe GERD
- -MOA: blocks the secretion of acid into the stomach by the parietal cells
- -Adverse Effects:
- -Patient Education: can sprinkle on applesauce; take 1 hour before meals; avoid alcohol
- -Other: protects esophagus so it can heal; may also strengthen LES
-
Prevacid
- -Generic: lansoprazole
- -Class: PPI
- -Indication: mod. to severe GERD
- -MOA: blocks the secretion of acid into the stomach by the parietal cells
- -Adverse Effects:
- -Patient Education: OTC; can sprinkle on applesauce; take 1 hour before meals; avoid alcohol
- -Other: protects esophagus so it can heal; may also strengthen LES
-
Protonix
- -Generic: pantoprazole
- -Class: PPI
- -Indication: mod. to severe GERD
- -MOA: blocks the secretion of acid into the stomach by the parietal cells
- -Adverse Effects:
- -Patient Education: Must swallow whole; take 1 hour before meals; avoid alcohol-Other: protects esophagus so it can heal; may also strengthen LES
-
Aciphex
- -Generic: rabeprazole
- -Class: PPI
- -Indication: mod. to severe GERD
- -MOA: blocks the secretion of acid into the stomach by the parietal cells
- -Adverse Effects:
- -Patient Education: Must swallow whole; take 1 hour before meals; avoid alcohol
- -Other: protects esophagus so it can heal; may also strengthen LES
-
Zantac
- -Generic: ranitidine
- -Class: H2 antagonist
- -Indication: treats mild to moderate GERD
- -MOA: bind H2 receptors on parietal cells preventing histamine-induced activation
- -Adverse Effects:
- -Patient Education: best if taken 30 minutes before a meal-Other: does Not heal inflammation; used in children <1 year
-
Pepcid
- -Generic: famotidine
- -Class: H2 antagonist
- -Indication: treats mild to moderate GERD
- -MOA: bind H2 receptors on parietal cells preventing histamine-induced activation
- -Adverse Effects:
- -Patient Education: best if taken 30 minutes before a meal
- -Other: does Not heal inflammation; adjust in renal insufficiency
-
Fosamax
- -Generic: alendronate
- -Class: bisphosphanate
- -Indication: prevention and treatment of osteoporosis in men, women
- -MOA: inhibit osteoclasts activity; reduces bone resorption and turnover
- -Adverse Effects: heartburn , indigestion, jaw bone pain
- -Patient Education:*Must follow proper administration technique
- -take first thing in the morning
- -take with a full glass of water
- -nothing other than water within 30 minutes
- -remain sitting or standing for at least 30 minutes
- -Other: combo tab with Vitamin D available; avoid in renal insufficiency -drug holiday
-
Actonel
- -Generic: risedronate
- -Class: bisphosphanate
- -Indication: prevention and treatment of osteoporosis in men, women
- -MOA: inhibit osteoclasts activity; reduces bone resorption and turnover
- -Adverse Effects: heartburn , indigestion, jaw bone pain
- -Patient Education:*Must follow proper administration technique
- -take first thing in the morning
- -take with a full glass of water
- -nothing other than water within 30 minutes
- -remain sitting or standing for at least 30 minutes
- -Other: avoid in renal insufficiency
-
Boniva
- -Generic: ibandronate
- -Class: bisphosphanate
- -Indication: prevention and treatment of osteoporosis in men, women
- -MOA: inhibit osteoclasts activity; reduces bone resorption and turnover
- -Adverse Effects: heartburn , indigestion, jaw bone pain
- -Patient Education:*Must follow proper administration technique
- -take first thing in the morning
- -take with a full glass of water
- -nothing other than water within 60 minutes
- -remain sitting or standing for at least 60 minutes
- -Other: avoid in renal insufficiency; APAP given at time of treatment
-
Evista
- -Generic: raloxifene
- -Class: SERM
- -Indication: osteoporosis, breast cancer, hormone replacement therapy
- -MOA: estrogen-like activity on the bones
- -Adverse Effects: hot flashes, night sweats, leg cramps, blood clots
- -Patient Education: avoid alcohol
- -Other: reduces risk of ER+ breast cancer; Pregnancy category x
-
Premarin
- -Generic: conjugated estrogens
- -Class: hormones
- -Indication: moderate to severe vasomotor symptoms
- -MOA:
- -Adverse Effects: vaginal bleeding, venous thromboembolism, stroke
- -Patient Education:
- -Other: increases risk of endometrial cancer in women with a uterus
-
Yaz, Ocella
- -Generic: ethinyl estradiol/ drospirenone
- -Class: Oral Contraceptive
- -Indication:
- -MOA: anti-mineralcorticoid activity
- -Adverse Effects:
- -Patient Education:
- -Other: avoid use in renal/adrenal insufficiency
-
TriNessa
- -Generic: ethinyl estradiol norgestimate
- -Class: Oral Contraceptive
- -Indication:
- -MOA:
- -Adverse Effects:
- -Patient Education:
- -Other:
-
Loestrin 24 Fe
- -Generic: ethinyl estradiol/ norethindrone
- -Class: Oral Contraceptive
- -Indication:
- -MOA:
- -Adverse Effects:
- -Patient Education:
- -Other:
-
NuvaRing
- -Generic: ethinyl estradiol/etonogestrel
- -Class: Contraceptive- IUD
- -Indication:
- -MOA:
- -Adverse Effects:
- -Patient Education: inserted every 3 weeks on day 1 of cycle; use back-up if removed >3 hours
- -Other:
-
Detrol LA
- -Generic: tolterodine
- -Class: antimuscarinic
- -Indication: UTI
- -MOA: competitive muscarinic receptor antagonist (dec. bladder contractions, detrusor pressure, incomplete voiding)
- -Adverse Effects: dry mouth, headache, constipation, blurred vision, dizziness
- -Patient Education: decreases urge and urination; may take weeks to months for full efficacy
- -Other: once (ER) or twice (IR) daily: reduce dose in hepatic/renal insufficiency
-
Flomax
- -Generic: tamsulosin
- -Class: alpha-1 adrenegic blocker
- -Indication: BPH
- -MOA:
- -Adverse Effects:orthostatic hypotension, dizziness, weakness, dec. libido, insomnia, rhinitis, abnormal ejaculations, ejaculatory problems, intraoperative floppy iris syndrome
- -Patient Education: 30 minutes after same meal everyday
- -Other: can use alone or with 5 alpha reductase inhibitor
-
Proscar
- -Generic: finasteride
- -Class: 5 alpha reductase inhibitor
- -Indication: BPH
- -MOA:
- -Adverse Effects: erectile dysfunction, dec. libido, inc. breast size/tenderness, rash
- -Patient Education: **Cat. X: pregnant women should not handle crushed or broken tablets; may also spread through semen
- -Other: use alone or with 5 alpha reductase inhibitor (use with doxazosin)
-
Viagra
- -Generic: sildenafil
- -Class: phosphodiesterase type 5 inhibitor
- -Indication: ED
- -MOA: inhibits cGMP (increased inflow of blood)
- -Adverse Effects:headache, flushing, dyspepsia, rhinitis, impaired color discrimination, dizziness, hypotension, CV effects, sudden hearing loss
- -Patient Education: take without food, 30-60 minutes before intercourse, use up to once daily; lasts up to 4 hours; avoid high fat foods, caution with alpha blockers and some antibiotics/antifungals
- -Other: **contraindicated with nitrates; grapefruit juice may increase concentration
-
Cialis
- -Generic: tadalafil
- -Class: phosphodiesterase type 5 inhibitor
- -Indication: ED
- -MOA: inhibits cGMP (increased inflow of blood)
- -Adverse Effects:headache, flushing, dyspepsia, rhinitis, impaired color discrimination, dizziness, hypotension, CV effects, sudden hearing loss
- -Patient Education: take with or without food, 30 minutes before intercourse, use up to once daily, lasts 24-36 hours, avoid high fat foods, caution with alpha blockers and some antibiotics/antifungals
- -Other: **contraindicated with nitrates; grapefruit juice may increase concentration; delayed effect- longer acting than Viagra
-
Yohimbe
- -Generic:
- -Class: herbal
- -Indication: ED (not recommended)
- -MOA: selective alpha 2 adrenergic blocker; vasodilatory; no proven efficacy
- -Adverse Effects: dizziness, anxiety, flushing, headache, hypertension, tachycardia, tremor
- -Patient Education:
- -Other:
-
Tussionex
- -Generic: chlorpheniramine and hydrocodone
- -Class: antitussive
- -Indication: cough relief
- -MOA:
- -Adverse Effects: drowsiness, constipation
- -Patient Education: shake well; avoid alcohol, >6 yoa
- -Other: habit forming
-
Antavert, Dramamine
- -Generic: meclizine
- -Class: histamine H1 antagonist (1st gen)
- -Indication: allergies
- -MOA:
- -Adverse Effects: dry mouth, eyes, constipation and urinary retention
- -Patient Education: dosed 4-6 hours
- -Other:
-
Vistaril
- -Generic: hydroxyzine
- -Class: 1st gen antihistamine
- -Indication:
- -MOA:
- -Adverse Effects:
- -Patient Education:
- -Other:
-
Allegra
- -Generic: fexofenadine
- -Class: 2nd gen antihistamine
- -Indication:
- -MOA:
- -Adverse Effects:
- -Patient Education:
- -Other:
-
Clarinex
- -Generic: desloratidine
- -Class:
- -Indication:
- -MOA:
- -Adverse Effects:
- -Patient Education:
- -Other:
-
Flexeril
- -Generic: cyclobenzaprine
- -Class: muscle relaxer
- -Indication:
- -MOA: CNS depressant: similar MOA to TCAs
- -Adverse Effects: drowsiness, dizziness, muscle weakness
- -Patient Education: avoid antidepressants and MAOis
- -Other:
-
Soma
- -Generic: carisoprodol
- -Class: muscle relaxer
- -Indication:
- -MOA:
- -Adverse Effects:
- -Patient Education:
- -Other:
-
Skelaxin
- -Generic: metaxalone
- -Class: alpha 2 adrenergic agonist
- -Indication: muscle relaxer
- -MOA: alpha 2 adrenergic agonist
- -Adverse Effects: hypotension, somnolence, dizziness, muscle weakness
- -Patient Education:
- -Other:
-
Zanaflex
- -Generic: tizanidine
- -Class: muscle relaxer
- -Indication:
- -MOA:
- -Adverse Effects:
- -Patient Education:
- -Other:
-
Robaxin
- -Generic: methocarbamol
- -Class: muscle relaxer
- -Indication:
- -MOA:
- -Adverse Effects:
- -Patient Education:
- -Other:
-
Aricept
- -Generic: donepezil
- -Class: acetylcholinesterase inhibitor
- -Indication: Alzheimer's (mild to moderate)
- -MOA: increases amounts of acetylcholine available in CNS
- -Adverse Effects: insomnia, nausea, diarrhea, GI upset
- -Patient Education: take at bedtime
- -Other: no cure for Alzheimer's
-
Namenda
- -Generic: memantine
- -Class: N-methyl-D-aspartate receptor antagonist
- -Indication: Alzheimer's
- -MOA: uncompetitive antagonist of glutamate receptors
- -Adverse Effects: HTN, HA, CNS effects
- -Patient Education:
- -Other:
-
Imitrex
- -Generic:
- -Class: Triptans (first line)
- -Indication:
- -MOA:
- -Adverse Effects:
- -Patient Education:
- -Other: available as a nasal spray
-
Reglan
- -Generic: metoclopramide
- -Class: pro-motility agent
- -Indication: GERD, nausea/vomiting, gastroparesis
- -MOA: increase the pressure in the lower esophageal sphincter and strengthen peristalsis of the stomach; speeds up stomach emptying
- -Adverse Effects: weakness, somnolence; Serious: tardive dyskinesia, neuroleptic malignant syndrome
- -Patient Education: take 30 minutes before meals and HS
- -Other: does not heal inflammation
|
|